These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors. Koch T; Wu DF; Yang LQ; Brandenburg LO; Höllt V J Neurochem; 2006 Apr; 97(2):365-72. PubMed ID: 16539674 [TBL] [Abstract][Full Text] [Related]
3. ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis. Koch T; Brandenburg LO; Schulz S; Liang Y; Klein J; Hollt V J Biol Chem; 2003 Mar; 278(11):9979-85. PubMed ID: 12519790 [TBL] [Abstract][Full Text] [Related]
4. mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2. Koch T; Seifert A; Wu DF; Rankovic M; Kraus J; Börner C; Brandenburg LO; Schröder H; Höllt V J Neurochem; 2009 Aug; 110(4):1288-96. PubMed ID: 19519662 [TBL] [Abstract][Full Text] [Related]
5. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. Koch T; Schulz S; Pfeiffer M; Klutzny M; Schröder H; Kahl E; Höllt V J Biol Chem; 2001 Aug; 276(33):31408-14. PubMed ID: 11359768 [TBL] [Abstract][Full Text] [Related]
6. Role of phospholipase D2/phosphatidic acid signal transduction in micro- and delta-opioid receptor endocytosis. Yang L; Seifert A; Wu D; Wang X; Rankovic V; Schröder H; Brandenburg LO; Höllt V; Koch T Mol Pharmacol; 2010 Jul; 78(1):105-13. PubMed ID: 20354103 [TBL] [Abstract][Full Text] [Related]
7. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. Beyer A; Koch T; Schröder H; Schulz S; Höllt V J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512 [TBL] [Abstract][Full Text] [Related]
8. Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor. Wolf R; Koch T; Schulz S; Klutzny M; Schröder H; Raulf E; Bühling F; Höllt V Mol Pharmacol; 1999 Feb; 55(2):263-8. PubMed ID: 9927617 [TBL] [Abstract][Full Text] [Related]
9. ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2. Rankovic M; Jacob L; Rankovic V; Brandenburg LO; Schröder H; Höllt V; Koch T Cell Signal; 2009 Dec; 21(12):1784-93. PubMed ID: 19666113 [TBL] [Abstract][Full Text] [Related]
10. A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization. Wang HL Neuropharmacology; 2000 Jan; 39(3):353-63. PubMed ID: 10698001 [TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. Kramer HK; Simon EJ J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731 [TBL] [Abstract][Full Text] [Related]
12. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists. Blanchet C; Sollini M; Lüscher C Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471 [TBL] [Abstract][Full Text] [Related]
13. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Kovoor A; Celver JP; Wu A; Chavkin C Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514 [TBL] [Abstract][Full Text] [Related]
15. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
16. A constitutively internalizing and recycling mutant of the mu-opioid receptor. Segredo V; Burford NT; Lameh J; Sadée W J Neurochem; 1997 Jun; 68(6):2395-404. PubMed ID: 9166733 [TBL] [Abstract][Full Text] [Related]
17. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353 [TBL] [Abstract][Full Text] [Related]
18. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. Koch T; Schulz S; Schröder H; Wolf R; Raulf E; Höllt V J Biol Chem; 1998 May; 273(22):13652-7. PubMed ID: 9593704 [TBL] [Abstract][Full Text] [Related]
19. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505 [TBL] [Abstract][Full Text] [Related]
20. Receptor density and recycling affect the rate of agonist-induced desensitization of mu-opioid receptor. Law PY; Erickson LJ; El-Kouhen R; Dicker L; Solberg J; Wang W; Miller E; Burd AL; Loh HH Mol Pharmacol; 2000 Aug; 58(2):388-98. PubMed ID: 10908307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]